PHGE: BiomX Inc Operating Profitability

BiomX Inc. (PHGE) - corporate logo

Tracking the operating margin of BiomX Inc. (PHGE) demonstrates the specifics of the biotech sector: -6759.30 shapes the current metric, as the absence of sales makes the company dependent on the outcome of phase II trials. Meanwhile, the development of phage therapy is not subject to economic cycles. Diversifying research into skin and lung pathologies helps mitigate overall risks when creating drugs against resistant infections.

PHGE: BiomX Inc Operating Profitability 07/04/2022 - 09/11/2026

Metric breakdowns and analytics for BiomX Ltd (PHGE)

- price and consensus price forecast:
- market capitalization information:
Comprehensive company analysis:BiomX Ltd
Core merchandise of BiomX Inc

Long-term investing requires strict control over operational efficiency, expressed as the ratio of earnings before interest and taxes to revenue. For BiomX Inc. (PHGE), with its intensive R&D expenditures during Phase II clinical trials, the operating profit margin demonstrates the business's ability to generate internal resources, defining the company's investment profile through the lens of development cost management efficiency.